Volitionrx (VNRX) Change in Account Payables (2011 - 2012)
Volitionrx (VNRX) posted Change in Account Payables of -$60173.0 for Q3 2012, up 33.74% on a QoQ basis from -$90816.0 in Q2 2012, and down 18.31% year-over-year from -$73663.2 in Q4 2011.
Volitionrx (VNRX) Change in Account Payables (2011 - 2012) Analysis & Trends
Volitionrx's Change in Account Payables history runs 2 years deep, the most recent figure standing at -$60173.0 for Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -60,173.00 |
| Sep 30, 2012 | -60,173.00 |
| Jun 30, 2012 | -90,816.00 |
| Jun 30, 2012 | -90,816.00 |
| Mar 31, 2012 | 66,908.00 |
| Mar 31, 2012 | 66,908.00 |
| Sep 30, 2011 | -50,859.00 |
| Sep 30, 2011 | -50,859.00 |
| Jun 30, 2011 | -3,684.00 |
| Jun 30, 2011 | -3,684.00 |
| Mar 31, 2011 | 19,869.00 |
| Mar 31, 2011 | 19,869.00 |